United States Steel Corp
Change company Symbol lookup
Select an option...
X United States Steel Corp
WM Waste Management Inc
CAG Conagra Brands Inc
SIRI Sirius XM Holdings Inc
K Kellogg Co
F Ford Motor Co
CPB Campbell Soup Co
T AT&T Inc
AA Alcoa Corp
GROW US Global Investors Inc
Go

Materials : Metals & Mining | Small Cap Value
Company profile

United States Steel Corporation (U.S Steel) is an integrated steel producer, which is engaged in producing and selling steel products, including flat-rolled and tubular products, in North America and Europe. The Company’s operations in the United States also include iron ore and coke production facilities and real estate operations. Its operations in Europe also include coke production facilities. It operates through four segments: North American Flat-Rolled (Flat-Rolled), Mini Mill, U.S. Steel Europe (USSE); and Tubular Products (Tubular). The Company owns approximately 45,000 acres of real estate assets, either held for development or managed, in Alabama, Illinois, Michigan, Minnesota and Pennsylvania. It performs a range of applied research, development, and technical support functions at facilities in Pennsylvania, Michigan, Texas and Slovakia. It serves customers primarily in the automotive, construction, consumer, electrical, industrial equipment, distribution and energy markets.

Price
Delayed
$17.57
Day's Change
0.515 (3.02%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.03
Day's Low
17.31
Volume
(Above Average)

Today's volume of 6,026,838 shares is on pace to be greater than X's 10-day average volume of 14,301,048 shares.

6,026,838

Lawsuits Filed Against Vrt, Abbv And Ibm - Jakubowitz Law Pursues Shareholders Claims

3:21 pm ET May 19, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 19, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Vertiv Holdings Co (NYSE:VRT)

CONTACT JAKUBOWITZ ABOUT VRT:

https://claimyourloss.com/securities/vertiv-holdings-co-loss-submission-form/?id=27486&from=1

This lawsuit is on behalf of persons and entities that: (a) purchased or otherwise acquired Vertiv securities between February 24, 2021, and February 23, 2022, inclusive; and/or (b) purchased Vertiv shares in or traceable to the Company's secondary public offering of Class A common stock conducted on or around November 4, 2021.

Lead Plaintiff Deadline : May 23, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company could not adequately respond to supply chain issues and inflation by increasing its prices; (2) as a result of the increasing costs, Vertiv's earnings would be adversely impacted; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

AbbVie Inc. (NYSE:ABBV)

CONTACT JAKUBOWITZ ABOUT ABBV:

https://claimyourloss.com/securities/abbvie-inc-loss-submission-form/?id=27486&from=1

Class Period : April 30, 2021 - August 31, 2021

Lead Plaintiff Deadline : June 6, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) safety concerns about Pfizer Inc.'s drug Xeljanz extended to Abbvie's drug Rinvoq and to other Janus kinase enzyme inhibitor drugs; (2) as a result, it was likely that the U.S. Food and Drug Administration would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

International Business Machines Corporation (NYSE:IBM)

CONTACT JAKUBOWITZ ABOUT IBM:

https://claimyourloss.com/securities/international-business-machines-corporation-loss-submission-form/?id=27486&from=1

Class Period : April 4, 2017 - October 20, 2021

Lead Plaintiff Deadline : June 6, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Strategic Imperatives Revenue and growth, CAMSS and CAMSS Components' revenue and growth, and the Company's Segments' revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (ii) the Company's present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (iii) the Company misled the market by portraying the Company's Strategic Imperative's financial performance and future prospects more favorable than they actually were as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.

Jakubowitz Law, Thursday, May 19, 2022, Press release picture

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW

1140 Avenue of the Americas

9th Floor

New York, New York 10036

T: (212) 867-4490

F: (212) 537-5887

SOURCE: Jakubowitz Law





View source version on accesswire.com:

https://www.accesswire.com/702083/Lawsuits-Filed-Against-Vrt-Abbv-And-Ibm--Jakubowitz-Law-Pursues-Shareholders-Claims



comtex tracking

COMTEX_407470225/2457/2022-05-19T15:21:11

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.